Abstract
Kawasaki disease (KD) often presents with abnormal urinary findings, such as aseptic pyuria, mild proteinuria and microscopic haematuria. In this study, we measured urinary interleukin-6 (IL-6) by a sensitive sandwich ELISA assay using mouse monoclonal antibodies against recombinant IL-6 to elucidate the role of IL-6 in the pathogenesis of renal lesions in KD. Serum IL-6 levels were increased in acute KD as well as in febrile controls. Importantly, urinary IL-6 levels were consistently elevated in patients with acute KD, but much lower in febrile controls. Urinary IL-6 levels returned steadily to normal during the convalescent phase. In addition to IL-6, urinary levels ofN-acetyl-β-d-glucosaminidase (NAG) and β2-microglobulin (β2-mg) were also elevated during the acute phase of this disease. Eosinophils and macrophages were identifiable in urinary sediments from these patients. The increased levels of urinary IL-6 in combination with increased NAG and β2-mg seemed to suggest the presence of certain renal parenchymal lesions with cellular infiltration during the acute phase of the disease. IL-6 may serve as clinically useful parameter for the detection and monitoring of the renal involvement in KD.
Similar content being viewed by others
Abbreviations
- β2-mg:
-
β2-microglobulin
- Cr:
-
creatinine
- CRP:
-
C-reactive protein
- IL-6:
-
Interleukin-6
- KD:
-
Kawasaki disease
- NAG:
-
N-acetyl-β-d-glucosaminidase
References
Amano S, Hazama F, Kubagawa H, Tasaka K, Haebara H, Hamashima Y (1980) On the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn 30:681–694
Colvin RB, Fang LS (1989) Interstitial nephritis. In: Tisher CC, Brenner BM (eds) Renal pathology with clinical and functional correlations. J B Lippincott Company. Washington, pp 728–776
Dance N, Price RG, Cattell WR, Lansdell J, Richards B (1970) The excretion ofN-acetyl-β-glucosaminidase and β-galactosidase by patients with renal disease. Clin Chim Acta 27:87–92
Ferriero DM, Wolfsdorf JI (1981) Hemolytic uremic syndrome associated with Kawasaki disease. Pediatrics 68:405–406
Hirano T, Kishimoto T (1990) Interleukin-6. In: Sporn MB, Roberts AB (eds) Handbook of experimental pharmacology. Springer-Verlag, Berlin Heidelberg New York, pp 633–655
Horii Y, Muraguchi A, Iwano M, Matsuda T, Hirayama T, Yamada H, Fujii Y, Dohi K, Ishikawa H, Ohmoto Y, Yoshozaki K, Hirano T, Kishimoto T (1989) Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 143:3949–3955
Kawasaki T (1967) MCLS: clinical observation of 50 cases (in Japanese). Jpn J Allergy 16:178–226
MacArdle BM, Chambers TL, Weller SDV (1983) Acute renal failure in Kawasaki disease. J R Soc Med 76:615–616
Ogawa H (1985) Kidney pathology in muco-cutaneous lymphnode syndrome. Jpn J Nephrol 27:1229–1237
Ohta K, Takano N, Seno A, Yachie A, Miyawaki T, Yokoyama H, Tomosugi N, Kato E, Taniguchi N (1992) Detection and clinical usefulness of urinary interleukin 6 in the diseases of the kidney and the urinary tract. Clin Nephrol 38:185–189
Patricia RNK (1982)N-acetyl-β-d-glucosaminidase in urine of patients with renal disease, and after renal transplants and surgery. Clin Chim Acta 119:89–97
Salcedo JR, Greenberg L, Kapur S (1988) Renal histology of mucocutaneous lymphnode syndrome (Kawasaki disease). Clin Nephrol 29:47–51
Wibell L (1985) Aspects on tubular proteinuria. Ups J Med Sci 90:5–14
Yap HK, Yip WC, Giam YC, Tay JS (1989) Nephrotic syndrome in Kawasaki disease. Aust Paediatr J 25:241–242
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ohta, K., Seno, A., Shintani, N. et al. Increased levels of urinary interleukin-6 in Kawasaki disease. Eur J Pediatr 152, 647–649 (1993). https://doi.org/10.1007/BF01955240
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01955240